HANH PHAM: Open Payments
NPI 1659931939 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,667 in 116 payments from 22 companies in 2025. Trend: 2023 $1,842 · 2024 $2,135 · 2025 $2,667
Food & beverage: $2,667
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $370 |
| Verona Pharma, Inc. | 18 | $361 |
| Regeneron Healthcare Solutions, Inc. | 9 | $275 |
| GENZYME CORPORATION | 8 | $204 |
| ANI Pharmaceuticals, Inc. | 6 | $176 |
| Grifols USA, LLC | 7 | $175 |
| Viatris Specialty LLC | 8 | $174 |
| GlaxoSmithKline, LLC. | 14 | $148 |
| Mallinckrodt Hospital Products Inc. | 6 | $132 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $119 |
Products named: DUPIXENT, Ohtuvayre, TEZSPIRE, PURIFIED CORTROPHIN GEL, Prolastin-C Liquid, YUPELRI, ACTHAR, GLASSIA.
Industry payments across MS — which companies pay providers there.
